Holen Sie sich die Stockscreener-App
7.10
2.61%
-0.19
Handel nachbörslich:
7.11
0.01
+0.14%
Lyra Therapeutics Inc Aktie (LYRA) Neueste Nachrichten
Lyra Therapeutics Faces Manufacturing and Staffing Challenges Amid LYR-210 Production Shift - TipRanks
What to do if you’re stuck in Lyra Therapeutics Inc.Jobs Report & Free Fast Entry Momentum Trade Alerts - Newser
Should you wait for a breakout in Lyra Therapeutics Inc.2025 Big Picture & Accurate Entry and Exit Point Alerts - Newser
Lyra Therapeutics shares rise 11.19% intraday after positive ENLIGHTEN 2 Phase 3 results and extended cash runway. - AInvest
Key metrics from Lyra Therapeutics Inc.’s quarterly dataWeekly Investment Summary & Expert Approved Trade Ideas - Newser
Chart based exit strategy for Lyra Therapeutics Inc.2025 Big Picture & High Conviction Buy Zone Picks - Newser
Why Lyra Therapeutics Inc. is moving todayMarket Sentiment Summary & Fast Momentum Stock Entry Tips - Newser
Developing predictive dashboards with Lyra Therapeutics Inc. dataShare Buyback & Free Reliable Trade Execution Plans - Newser
Lyra Therapeutics 2025 Q2 Earnings Significant Loss Reduction - AInvest
Lyra Therapeutics reports Q2 EPS ($5.51), consensus ($4.78) - MSN
Lyra Therapeutics Reports Q2 2025 Financial Results - TipRanks
Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Risk vs reward if holding onto Lyra Therapeutics Inc.Market Risk Analysis & Reliable Price Action Trade Plans - Newser
Lyra Therapeutics Q2 2025 Earnings: Revenue of $183K Surpasses Forecast, EPS of -$5.51 Beats Estimate - AInvest
Lyra Therapeutics Posts 85% Drop in Q2 Loss, Positive LYR-210 Clinical Trial Results Position Company for Regulatory Meeting - AInvest
Building trade automation scripts for Lyra Therapeutics Inc.Free Early Entry Tips With Low Risk Zone - Newser
Lyra Therapeutics Posts 85% Q2 Loss Drop - Nasdaq
Can trapped investors hope for a rebound in Lyra Therapeutics Inc.Historical Stock Summary and ROI Review - Newser
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Lyra Therapeutics: Navigating Financial Challenges on the Road to Profitability - AInvest
Lyra Therapeutics Q2 rev. up 9% YoY, cash runway extended to 3Q 2026. - AInvest
LYRA THERAPEUTICS Earnings Results: $LYRA Reports Quarterly Earnings - Quiver Quantitative
Lyra Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Using economic indicators to assess Lyra Therapeutics Inc. potentialInstitutional Holding Behavior Pattern Analysis - Newser
Lyra's Nasal Implant Shows Promise in Phase 3 Trial, Extends Cash Runway Through 2026 - Stock Titan
Real time breakdown of Lyra Therapeutics Inc. stock performanceSwing Trade Signal and Price Prediction - Newser
What makes Lyra Therapeutics Inc. stock price move sharplyPortfolio Allocation Strategy for Stability - Newser
Understanding Lyra Therapeutics Inc.’s price movementOversold Reversal Picks with Buy Zone - Newser
Sentiment analysis tools applied to Lyra Therapeutics Inc.Trade Alert System with Volume Analysis - Newser
Custom strategy builders for tracking Lyra Therapeutics Inc.Free Daily Profit Focused Stock Screener - Newser
Is Lyra Therapeutics Inc. stock reversal real or fakeBuy Strategy Review With Performance Summary - Newser
What earnings revisions data tells us about Lyra Therapeutics Inc.Smart Entry Watchlist with Daily Analysis - Newser
Chart overlay techniques for tracking Lyra Therapeutics Inc.Free Low Risk Picks for Daily Trading - Newser
Lyra Therapeutics Inc. stock trendline breakdownDaily Swing Candidate Analysis with Chart Patterns - Newser
RSI + MACD Show Convergence for Lyra Therapeutics Inc.Scalable Portfolio Growth Suggestions Released - metal.it
Lyra Therapeutics (LYRA) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Published on: 2025-08-11 02:07:15 - Newser
Will Lyra Therapeutics Inc. rebound enough to break evenFree Short Term Trading Opportunity Watch - Newser
Predicting Lyra Therapeutics Inc. trend using moving averagesFree AI Powered High Return Stock Calls - Newser
Is it time to cut losses on Lyra Therapeutics Inc.Free AI-Powered Trade Planning with Indicators - Newser
Why Lyra Therapeutics Inc. stock attracts strong analyst attentionSafe Momentum Strategy With Trend Analysis - Newser
How to use a screener to detect Lyra Therapeutics Inc. breakoutsWeekly High Conviction Trade Setup Analysis - Newser
Is Lyra Therapeutics Inc. stock poised for growthSmart Risk Strategy with Entry Optimization - Newser
Lyra Therapeutics Inc expected to post a loss of $6.02 a shareEarnings Preview - TradingView
Published on: 2025-08-06 20:20:47 - Newser
Real time alert setup for Lyra Therapeutics Inc. performanceFree Market Momentum and Signal Alerts - Newser
Is it the right time to buy Lyra Therapeutics Inc. stockGet expert analysis on top stock picks - Jammu Links News
Real time scanner hits for Lyra Therapeutics Inc. explainedHigh Yield Watchlist with Filtered Picks - Newser
0.11%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):